Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 400715-69-7 | MDL No. : | MFCD27952698 |
Formula : | C12H10ClNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VAKMSXIMRSCPQU-UHFFFAOYSA-N |
M.W : | 251.67 | Pubchem ID : | 22350710 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 63.04 |
TPSA : | 52.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.58 cm/s |
Log Po/w (iLOGP) : | 2.85 |
Log Po/w (XLOGP3) : | 3.18 |
Log Po/w (WLOGP) : | 3.17 |
Log Po/w (MLOGP) : | 1.74 |
Log Po/w (SILICOS-IT) : | 3.25 |
Consensus Log Po/w : | 2.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.62 |
Solubility : | 0.0606 mg/ml ; 0.000241 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.95 |
Solubility : | 0.0282 mg/ml ; 0.000112 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.86 |
Solubility : | 0.00349 mg/ml ; 0.0000139 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.81 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 13575-16-1 ]
Ethyl 5-phenyloxazole-2-carboxylate
Similarity: 0.87
[ 106833-79-8 ]
2-Phenyloxazole-5-carboxylic acid
Similarity: 0.62
[ 27383-92-2 ]
Methyl 5-chlorobenzo[d]oxazole-2-carboxylate
Similarity: 0.74
[ 323579-00-6 ]
2-Methyl-5-chloro-6-benzoxazolamine
Similarity: 0.62
[ 5043-81-2 ]
Methyl 3-amino-5-chloro-2-hydroxybenzoate
Similarity: 0.60
[ 905807-66-1 ]
Methyl 6-(benzyloxy)-4-chloroquinoline-2-carboxylate
Similarity: 0.60
[ 63816-18-2 ]
6-Chloro-2-methylbenzo[d]oxazole
Similarity: 0.60
[ 13575-16-1 ]
Ethyl 5-phenyloxazole-2-carboxylate
Similarity: 0.87
[ 27383-92-2 ]
Methyl 5-chlorobenzo[d]oxazole-2-carboxylate
Similarity: 0.74
[ 27383-91-1 ]
Methyl 5-methylbenzo[d]oxazole-2-carboxylate
Similarity: 0.64
[ 954239-61-3 ]
Methyl 5-bromobenzo[d]oxazole-2-carboxylate
Similarity: 0.61
[ 954239-67-9 ]
Methyl 6-bromobenzo[d]oxazole-2-carboxylate
Similarity: 0.61
[ 13575-16-1 ]
Ethyl 5-phenyloxazole-2-carboxylate
Similarity: 0.87
[ 106833-79-8 ]
2-Phenyloxazole-5-carboxylic acid
Similarity: 0.62